Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)
| Status: | Completed |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2011 |
| End Date: | November 2014 |
A Randomized, Controlled Clinical Trial Comparing the Use of Intravenous Tranexamic Acid With Aquamantys Bipolar Sealer for Blood Loss Reduction in Primary Total Knee Arthroplasty
The aim of the study is to determine if the use of iv TXA or Aquamantys system improve the
postoperative hemoglobin and hematocrit after primary TKA and what is the effect of the
simultaneous use of iv TXA and Aquamantys on the postoperative hemoglobin and hematocrit.
The assumption is that the combination of iv TXA and Aquamantys system will enable an
improvement in the postoperative hemoglobin and hematocrit equal or larger than the
improvement generated by the use of Aquamantys system alone.
postoperative hemoglobin and hematocrit after primary TKA and what is the effect of the
simultaneous use of iv TXA and Aquamantys on the postoperative hemoglobin and hematocrit.
The assumption is that the combination of iv TXA and Aquamantys system will enable an
improvement in the postoperative hemoglobin and hematocrit equal or larger than the
improvement generated by the use of Aquamantys system alone.
The study is randomized, placebo controlled. The study population includes patients older
than 18 years of age undergoing elective total primary knee replacement under spinal
anesthesia. All patients enrolled in the study will undergo TKA performed by the same
orthopedic surgeon. Since controversies exist regarding the effect of different types of
anesthesia (general anesthesia versus spinal or epidural anesthesia) on intraoperative blood
loss, in order to eliminate an important confounding variable we decided to exclusively
enroll for our study patients that qualify for and agree with spinal anesthesia to be used
as the main anesthetic technique for their TKA.
All clinical trial procedures will be performed by personnel blinded to study treatment
assignment. Unblinding is only allowed for safety concerns in an emergency situation.The
only other exception is represented by the surgeon, who can't be blinded in regards to using
Aquamantys system and the bipolar sealer. Once a subject becomes eligible for the trial, the
investigator or the designee will access the randomization system.
Enrolled subjects will be assigned to one of the 4 groups by block randomization of
alternating 4 and 8 and 12 patients per block. The Pharmacy Department will provide the iv
placebo or the iv TXA according to the randomization process.
This clinical trial will be conducted in accordance to this protocol, Good Clinical Practice
and applicable regulatory requirements
than 18 years of age undergoing elective total primary knee replacement under spinal
anesthesia. All patients enrolled in the study will undergo TKA performed by the same
orthopedic surgeon. Since controversies exist regarding the effect of different types of
anesthesia (general anesthesia versus spinal or epidural anesthesia) on intraoperative blood
loss, in order to eliminate an important confounding variable we decided to exclusively
enroll for our study patients that qualify for and agree with spinal anesthesia to be used
as the main anesthetic technique for their TKA.
All clinical trial procedures will be performed by personnel blinded to study treatment
assignment. Unblinding is only allowed for safety concerns in an emergency situation.The
only other exception is represented by the surgeon, who can't be blinded in regards to using
Aquamantys system and the bipolar sealer. Once a subject becomes eligible for the trial, the
investigator or the designee will access the randomization system.
Enrolled subjects will be assigned to one of the 4 groups by block randomization of
alternating 4 and 8 and 12 patients per block. The Pharmacy Department will provide the iv
placebo or the iv TXA according to the randomization process.
This clinical trial will be conducted in accordance to this protocol, Good Clinical Practice
and applicable regulatory requirements
Inclusion Criteria:
- Adult patients over age of 18 undergoing elective total primary knee arthroplasty
under spinal anesthesia.
Exclusion Criteria:
- Previous adverse reaction to tranexamic acid
- Congenital or acquired coagulation disorders
- Preoperative platelet count of less than 100,000/microliter or INR> 1.4
- History of deep venous thrombosis, pulmonary embolism or cerebrovascular accident
- Patients with acquired defective color vision
- Renal insufficiency (Glomerular filtration rate <20 ml/min)
- Severe liver disease
- Coronary stents
- Pregnant patients
- Main anesthetic other than spinal anesthesia
We found this trial at
1
site
Eastern Maine Medical Center Located in Bangor, Eastern Maine Medical Center (EMMC) serves communities throughout...
Click here to add this to my saved trials
